About BIOGENIC PHARMA – DOUBLE YOHIMBINE Biogenic pharma
Double Yohimbine is a thermogenic alkaloid compound extracted from Pausinystalia yohimbe bark, manufactured by Biogenic Pharma for laboratory research applications. This formulation combines yohimbine hydrochloride with complementary alkaloids to investigate alpha-2 adrenergic receptor antagonism and metabolic pathway modulation in controlled experimental settings. Researchers at Stroid UK Shop examine this compound’s interaction with lipolytic enzymes and thermogenic mechanisms in cellular models.
Laboratory Applications
Research scientists study Double Yohimbine’s effects on alpha-2 adrenergic receptor binding and downstream signalling pathways involved in adipocyte metabolism. The compound demonstrates particular utility in examining sympathetic nervous system modulation and cyclic adenosine monophosphate elevation in fat cell cultures. Investigators evaluate its potential interactions with other thermogenic compounds and its influence on norepinephrine release mechanisms. Studies often compare its activity profile against standard yohimbine preparations to assess the dual-alkaloid formulation’s enhanced research value.
Research Specifications
| Parameter | Specification |
|---|---|
| Manufacturer | Biogenic Pharma |
| Active Compounds | Yohimbine HCl + Alkaloid Complex |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage Requirements | Cool, dry environment away from light |
| Research Applications | Alpha-2 receptor studies, thermogenesis research |
The formulation’s dual-alkaloid approach provides researchers with enhanced experimental versatility compared to single-compound preparations. Scientists frequently incorporate this compound into studies alongside selective modulators and metabolic peptides to examine comprehensive thermogenic pathway interactions.
Research Compliance
This product is manufactured exclusively for in-vitro laboratory research purposes. Double Yohimbine is not intended for human consumption, clinical application, or therapeutic use. Researchers must maintain appropriate laboratory protocols and safety standards when handling this compound. All experimental work should be conducted in approved research facilities by qualified personnel.
